Loading company…
Vascular Pharmaceuticals develops therapies for diabetic nephropathy.
Vascular Pharmaceuticals develops treatments for diabetic nephropathy. Its lead product, VPI-2960B, was in Phase 2 clinical trials. The company was founded in 2005 and is based in Burlington, US. In February 2015, it raised USD 9 mn in a Series A round led by Lumira Ventures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in